Targeting the RAF/MEK/ERK, PI3K/AKT and P53 pathways in hematopoietic drug resistance

Samankaltaisia teoksia

• ROLES OF THE RAF/MEK/ERK PATHWAY IN CELL GROWTH, MALIGNANT TRANSFORMATION AND DRUG RESISTANCE
  Tekijä: McCubrey, James A., et al.
  Julkaistu: (2006)
• The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy
  Tekijä: Abrams, Stephen L., et al.
  Julkaistu: (2010)
• Dominant roles of the Raf/MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs
  Tekijä: Steelman, Linda S., et al.
  Julkaistu: (2010)
• Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
  Tekijä: Chappell, William H., et al.
  Julkaistu: (2011)
• Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
  Tekijä: Steelman, Linda S., et al.
  Julkaistu: (2011)